DE3017015C2 - - Google Patents

Info

Publication number
DE3017015C2
DE3017015C2 DE3017015A DE3017015A DE3017015C2 DE 3017015 C2 DE3017015 C2 DE 3017015C2 DE 3017015 A DE3017015 A DE 3017015A DE 3017015 A DE3017015 A DE 3017015A DE 3017015 C2 DE3017015 C2 DE 3017015C2
Authority
DE
Germany
Prior art keywords
mmol
added
ether
compound
diazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3017015A
Other languages
German (de)
English (en)
Other versions
DE3017015A1 (de
Inventor
Thomas R. Madeira Ohio Us Blohm
Brian W. Mason Ohio Us Metcalf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of DE3017015A1 publication Critical patent/DE3017015A1/de
Application granted granted Critical
Publication of DE3017015C2 publication Critical patent/DE3017015C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19803017015 1979-05-02 1980-05-02 Steroide, verfahren zu ihrer herstellung und sie enthaltende zubereitungen Granted DE3017015A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3535779A 1979-05-02 1979-05-02
US6974179A 1979-08-27 1979-08-27

Publications (2)

Publication Number Publication Date
DE3017015A1 DE3017015A1 (de) 1980-11-20
DE3017015C2 true DE3017015C2 (fr) 1989-04-20

Family

ID=26712031

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803017015 Granted DE3017015A1 (de) 1979-05-02 1980-05-02 Steroide, verfahren zu ihrer herstellung und sie enthaltende zubereitungen

Country Status (16)

Country Link
AT (1) AT390794B (fr)
AU (1) AU532558B2 (fr)
CA (1) CA1154008A (fr)
CH (1) CH643863A5 (fr)
DE (1) DE3017015A1 (fr)
DK (1) DK166501B1 (fr)
ES (1) ES8105012A1 (fr)
FR (1) FR2455610A1 (fr)
GB (1) GB2048888B (fr)
IE (1) IE49704B1 (fr)
IL (1) IL59934A (fr)
IT (1) IT1188932B (fr)
NL (1) NL191387C (fr)
NO (1) NO154884C (fr)
NZ (1) NZ193527A (fr)
SE (1) SE448097B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8503940D0 (en) * 1985-02-15 1985-03-20 Erba Farmitalia 4-substituted androstendione derivatives
NZ239141A (en) * 1990-08-01 1994-04-27 Merrell Dow Pharma 4-amino-delta-4,6-steroids; preparatory processes and pharmaceutical compositions
AU637247B2 (en) * 1990-08-01 1993-05-20 Merrell Dow Pharmaceuticals Inc. 4-amino-delta4-steroids and their use as 5alpha-reductase inhibitors
US5143909A (en) * 1991-03-19 1992-09-01 Merrell Dow Pharmaceuticals Inc. Aminosteroids in a method for inhibiting c17-20 lyase
EP0794456B1 (fr) 1996-03-07 2003-01-29 Agfa-Gevaert Procédé de reproduction d'une image médicale mémorisée électroniquement sur matériau photographique sensible à la lumière

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917829A (en) * 1971-11-08 1975-11-04 Research Corp Novel methods of inhibiting the activity of testosterone 5{60 -reductase
US4088760A (en) * 1976-06-23 1978-05-09 Richardson-Merrell Inc. Testosterone 5α-reductase inhibitors

Also Published As

Publication number Publication date
ES491010A0 (es) 1981-05-16
IT8048559A0 (it) 1980-04-30
GB2048888B (en) 1983-05-25
ATA232880A (de) 1989-12-15
NZ193527A (en) 1984-10-19
FR2455610A1 (fr) 1980-11-28
ES8105012A1 (es) 1981-05-16
AU5774780A (en) 1980-11-06
IT8048559A1 (it) 1981-10-30
IT1188932B (it) 1988-01-28
CA1154008A (fr) 1983-09-20
IE800806L (en) 1980-11-02
IL59934A0 (en) 1980-06-30
AU532558B2 (en) 1983-10-06
CH643863A5 (de) 1984-06-29
SE8003242L (sv) 1980-11-03
IL59934A (en) 1983-06-15
NO154884B (no) 1986-09-29
NL8002529A (nl) 1980-11-04
SE448097B (sv) 1987-01-19
NL191387C (nl) 1995-07-03
NO801254L (no) 1980-11-03
DE3017015A1 (de) 1980-11-20
FR2455610B1 (fr) 1982-04-30
NO154884C (no) 1987-01-07
IE49704B1 (en) 1985-11-27
GB2048888A (en) 1980-12-17
AT390794B (de) 1990-06-25
DK194180A (da) 1980-11-03
NL191387B (nl) 1995-02-01
DK166501B1 (da) 1993-06-01

Similar Documents

Publication Publication Date Title
US4317817A (en) Novel steroid 5α-reductase inhibitors
DE68921174T2 (de) Phosphinsäure-Derivate von aromatischen Steroiden als 5-alpha Reduktase-Inhibitoren.
DE3124780C2 (fr)
DE69027262T2 (de) 4-Substitutiertes 17-beta-(Cyclopropyloxy)androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase
EP0701565A1 (fr) Nouveaux derives de prednisolone
DE3124719C2 (de) 10-(1,2-Propadienyl)-östr-4-en-3,17-dion, entsprechendes Zwischenprodukt und pharmazeutische Zubereitungen, die diese Verbindungen enthalten
DE3017015C2 (fr)
DD145919B1 (de) Verfahren zur herstellung von 14,1 -methylenderivaten der oestranreihe
DE3336292C2 (fr)
DE69330465T2 (de) Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4-aza-5 alpha-androst-1-en-3-one
CH621560A5 (en) Process for the preparation of 3-ketosteroids disubstituted in position 16
DE2954699C2 (fr)
DE3402330A1 (de) 1(alpha),2(alpha)-methylen-6-methylen- und 6(alpha)-methyl-pregnene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
CH634083A5 (de) Verfahren zur herstellung neuer kortikoide.
DE2711516C2 (de) 17-Spirosultin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE4326240A1 (de) 15,15-Dialkyl-substituierte Derivate des Estradiols
DE2933258A1 (de) Neue acetylenische derivate des androst-4-ens, deren herstellungsverfahren, deren verwendung als arzneimittel und die diese enthaltenden pharmazeutischen zusammensetzungen
DE69023721T2 (de) In 3-Position Nitro-substituierte Steroid-Derivate.
DE3040200C2 (fr)
DE2348197C3 (de) Norethisteron-O-alkyloxime, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE4447401A1 (de) 14,17-C¶2¶-überbrückte Steroide
DE68912422T2 (de) 19-Fluor- oder Cyano-21-hydroxy-progesteron-Derivate als 19-Hydroxylase-Inhibitoren.
DE60026608T2 (de) 3-methylen steroid derivate zur behandlung von autoimmunerkrankungen
DE2100319C3 (de) Neue Östranverbindungen, ihre Herstellung und sie enthaltende Arzneimittel
DE2651364A1 (de) Neue d-homosteroide

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition